Diabetes & Endocrinology Perspective

 
 
  • How Hubris Impairs the Care of the Elderly Some conditions in older adults warrant treatment; some do not. The wise physician knows the difference.
  • Detecting Diabetic Retinopathy: Can AI Provide a Better Way? The inevitable advance of artificial intelligence has begun with the first approved system that can detect diabetic retinopathy on its own. How might it affect clinicians who screen for eye disease?
  • Simple Tool Predicts 2-Year Diabetes Risk An operational question about allocating diabetes resources results in a simple algorithm that identifies the people at highest risk for developing diabetes.
  • Formulary Snafus In an era of competing formularies and demands for preauthorization, taking a prescription to the pharmacy is often the beginning of a frustrating misadventure for patients and physicians alike.
  • Top 5 GI Topics for the PCP What are the top five topics that gastroenterologists read about in the past 12 months that may change the primary care management of gastrointestinal diseases?
  • A 48-Year-Old Woman With a Thyroid Mass: USMLE Question A 48-year-old woman presents with an asymptomatic thyroid mass. Can you make the diagnosis?
  • How Many Kids Really Have High Blood Pressure? The normative values for BP have been updated. A new analysis shows that, as a result, more children are classified as having elevated readings.
  • Preimplantation Genetic Testing for Aneuploidy Perhaps coming soon to a fertility clinic near you, this IVF method offers advantages in the management of infertility.
  • Changing the World, One Female Physician at a Time Do you recognize these women physician pioneers?
  • We Can't Just Give Up on Obesity A pediatric endocrinologist describes the harsh realities of practicing in the South today and calls on the medical profession to redress 'sins of the past.'
  • ECO 2018 Read clinically focused news coverage of key developments from ECO 2018
  • ACP Glycemic Target Guidance: An Author Makes the Case   Dr Jay H. Shubrook interviews Dr Timothy J. Wilt on ACP's updated guidance statement on pharmacologic treatment of nonpregnant patients with type 2 diabetes mellitus.
  • Duchenne Muscular Dystrophy: New Resource to Guide Clinical Care   Comprehensive new resources guide clinicians in all settings to provide optimal care to patients with Duchenne muscular dystrophy.
  • Extreme Diets: Fads and Facts Radical diets have exploded in popularity since the 19th century. We dig into notable examples -- from Fletcherism to liquid diets to Beverly Hills -- reviewing their history, claims, and impact.
  • NAFLD Is a Growing Problem Recent guidance from the American Association for the Study of Liver Diseases for the evaluation and management of patients with nonalcoholic fatty liver disease is profiled.
  • Hormone Therapy and Risk for Cancer in BRCA1 Mutation Carriers   Dr Andrew Kaunitz discusses the impact of hormone therapy on risk for breast cancer in BRCA carriers undergoing risk-reduction surgery.
  • SGLT2 Inhibitors: Unreal Primary Prevention? These diabetes drugs offer cardiovascular benefits, but only in diabetes patients who already have CV disease, the author argues.
  • Mitochondrial Diseases: Current State of Understanding   Mitochondrial diseases can affect any system by causing any symptom in any organ by any mode of inheritance.
  • AACE 2018 Read clinically focused news coverage of key developments from AACE 2018.
  • Should We View Obesity as Normal and Okay?   Many people say that obesity is normal. An expert says we shouldn't shame people because they're fat, but we shouldn't concede that being fat is normal either, because it is unhealthy.